CO-DELETION OF 1P/19Q AS PROGNOSTIC AND PREDICTIVE BIOMARKER IN THE LONG-TERM FOLLOW UP OF ANAPLASTIC OLIGODENDROGLIOMA PATIENTS

被引：0
|
作者：
Polivka, J., Jr. [1 ,2 ]
Polivka, J. [3 ,4 ]
Rohan, V. [3 ,4 ]
Repik, T. [3 ,4 ]
Hes, O. [5 ]
Topolcan, O. [6 ]
机构：
[1] Charles Univ Prague, Fac Med Plzen, Dept Histol & Embryol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med Plzen, Biomed Ctr, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med Plzen, Dept Neurol, Prague, Czech Republic
[4] Fac Hosp Plzen, Plzen, Czech Republic
[5] Charles Univ Prague, Fac Med Plzen, Dept Pathol, Prague, Czech Republic
[6] Fac Hosp Plzen, Cent Imunoanalyt Lab, Plzen, Czech Republic
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
84
引用
收藏
页码：6843 / 6843
页数：1
相关论文
共 50 条
  • [41] IS LOH 1P/19Q OF PROGNOSTIC RELEVANCE IN OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA-BUT NOT IN PURE ASTROCYTOMA?
    Suchorska, Bogdana
    Mehrkens, Jan H.
    Eigenbrod, Sabina
    Eroes, Christian A.
    Tonn, Joerg C.
    Kretzschmar, Hans A.
    Kreth, Friedrich V.
    NEURO-ONCOLOGY, 2010, 12 : 63 - 63
  • [42] The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
    McDonald, JM
    See, SJ
    Tremont, IW
    Colman, H
    Gilbert, MR
    Groves, M
    Burger, PC
    Louis, DN
    Giannini, C
    Fuller, G
    Passe, S
    Blair, H
    Jenkins, RB
    Yang, H
    Ledoux, A
    Aaron, J
    Tipnis, U
    Zhang, W
    Hess, K
    Aldape, K
    CANCER, 2005, 104 (07) : 1468 - 1477
  • [43] PROGNOSTIC VALUE OF MGMT METHYLATION STATUS IN PATIENTS WITH 1P/19Q INTACT ANAPLASTIC GLIOMAS
    Franceschi, Enrico
    Tosoni, Alicia
    Ermani, Mario
    Sturiale, Carmelo
    Dall'Occa, Patrizia
    Pession, Annalisa
    Di Oto, Enrico
    Morandi, Luca
    Bartolini, Stefania
    Brandes, Alba A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] ANAPLASTIC OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA WITHOUT 1P-19Q CO-DELETION: A MONO-INSTITUTIONAL RETROSPECTIVE STUDY
    Silvani, A.
    Gaviani, P.
    Simonetti, G.
    Innocenti, A.
    Farinotti, M.
    Finocchiaro, G.
    Lamperti, E.
    Botturi, A.
    Pollo, B.
    DiMeco, F.
    NEURO-ONCOLOGY, 2016, 18 : 28 - 28
  • [45] Co-Deletion of Chromosome 1p/19q and IDH1/2 Mutation in Glioma Subsets of Brain Tumors in Chinese Patients
    Ren, Xiaohui
    Cui, Xiangli
    Lin, Song
    Wang, Junmei
    Jiang, Zhongli
    Sui, Dali
    Li, Jing
    Wang, Zhongcheng
    PLOS ONE, 2012, 7 (03):
  • [46] Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
    Kha, Quang-Hien
    Le, Viet-Huan
    Hung, Truong Nguyen Khanh
    Le, Nguyen Quoc Khanh
    CANCERS, 2021, 13 (21)
  • [47] THE CORRELATION BETWEEN RESULTS OF COMPLEX TREATMENT AND 1P/19Q DELETION FOR PATIENTS WITH ANAPLASTIC OLIGODENDROGLIAL TUMORS
    Apskalne, D.
    Ozola, A.
    Bicans, K.
    Ozols, R.
    Auslands, K.
    NEURO-ONCOLOGY, 2014, 16
  • [48] Accuracy of MRI in Detecting 1p/19q Co-deletion Status of Gliomas: A Single-Center Retrospective Study
    Naeem, Adnan
    Aziz, Namrah
    Nasir, Manal
    Rangwala, Hussain Sohail
    Fatima, Hareer
    Mubarak, Fatima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [49] Anaplastic oligodendroglioma: Distinctive morphologic and immunophenotypic subsets associated with combined 1p/19q allelic loss
    Seethala, RR
    Ribalta, T
    Aldalpe, KD
    McDonald, JM
    Fuller, GN
    MODERN PATHOLOGY, 2005, 18 : 294A - 295A
  • [50] GENETIC AND HISTOLOGICAL STABILITY OF OLIGODENDROGLIAL TUMORS WITH 1P/19Q CO-DELETION EVEN AFTER CHEMOTHERAPY AND OR RADIATION THERAPY
    Ueki, Keisuke
    Aihara, Koki
    Mukasa, Akitake
    Higuchi, Fumi
    Matsuda, Hazki
    Kim, Phyo
    NEURO-ONCOLOGY, 2014, 16
12345